Fidelity International’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246M | Sell |
8,751,327
-499,825
| -5% | -$13.3M | 0.19% | 134 |
|
|
2025
Q4 | $230M | Sell |
9,251,152
-2,632,764
| -22% | -$66.4M | 0.17% | 150 |
|
|
2025
Q3 | $303M | Buy |
11,883,916
+2,611,899
| +28% | +$64.5M | 0.24% | 106 |
|
|
2025
Q2 | $225M | Buy |
9,272,017
+1,403,754
| +18% | +$32.7M | 0.19% | 132 |
|
|
2025
Q1 | $199M | Buy |
7,868,263
+1,079,751
| +16% | +$28.3M | 0.19% | 137 |
|
|
2024
Q4 | $180M | Buy |
6,788,512
+1,512,801
| +29% | +$41M | 0.17% | 153 |
|
|
2024
Q3 | $153M | Sell |
5,275,711
-2,515,130
| -32% | -$73.4M | 0.14% | 183 |
|
|
2024
Q2 | $218M | Sell |
7,790,841
-1,516,607
| -16% | -$41.8M | 0.22% | 129 |
|
|
2024
Q1 | $258M | Buy |
9,307,448
+1,724,930
| +23% | +$47.9M | 0.26% | 110 |
|
|
2023
Q4 | $218M | Buy |
7,582,518
+3,734,595
| +97% | +$113M | 0.23% | 120 |
|
|
2023
Q3 | $128M | Buy |
3,847,923
+730,146
| +23% | +$25.8M | 0.15% | 174 |
|
|
2023
Q2 | $114M | Buy |
3,117,777
+2,916,148
| +1,446% | +$114M | 0.13% | 181 |
|
|
2023
Q1 | $8.23M | Buy |
201,629
+22,142
| +12% | +$956K | 0.01% | 506 |
|
|
2022
Q4 | $9.2M | Buy |
179,487
+15,902
| +10% | +$762K | 0.01% | 507 |
|
|
2022
Q3 | $7.16M | Sell |
163,585
-21,825
| -12% | -$1.06M | 0.01% | 539 |
|
|
2022
Q2 | $9.72M | Sell |
185,410
-18,774
| -9% | -$957K | 0.01% | 500 |
|
|
2022
Q1 | $10.6M | Sell |
204,184
-46,503
| -19% | -$2.41M | 0.01% | 528 |
|
|
2021
Q4 | $14.8M | Sell |
250,687
-1,857,900
| -88% | -$92.1M | 0.02% | 487 |
|
|
2021
Q3 | $90.7M | Sell |
2,108,587
-2,226,687
| -51% | -$98.6M | 0.1% | 212 |
|
|
2021
Q2 | $170M | Sell |
4,335,274
-345,460
| -7% | -$13.4M | 0.18% | 143 |
|
|
2021
Q1 | $170M | Sell |
4,680,734
-2,404,770
| -34% | -$85.4M | 0.19% | 138 |
|
|
2020
Q4 | $261M | Sell |
7,085,504
-6,788,029
| -49% | -$249M | 0.32% | 74 |
|
|
2020
Q3 | $483M | Sell |
13,873,533
-3,642,272
| -21% | -$128M | 0.6% | 33 |
|
|
2020
Q2 | $543M | Buy |
17,515,805
+1,747,301
| +11% | +$59.4M | 0.73% | 24 |
|
|
2020
Q1 | $488M | Buy |
15,768,504
+8,369,878
| +113% | +$285M | 0.8% | 24 |
|
|
2019
Q4 | $275M | Buy |
7,398,626
+2,669,026
| +56% | +$95.1M | 0.38% | 63 |
|
|
2019
Q3 | $161M | Sell |
4,729,600
-4,949,247
| -51% | -$180M | 0.24% | 107 |
|
|
2019
Q2 | $398M | Buy |
9,678,847
+5,800,513
| +150% | +$230M | 0.6% | 36 |
|
|
2019
Q1 | $156M | Sell |
3,878,334
-4,151,006
| -52% | -$166M | 0.24% | 118 |
|
|
2018
Q4 | $333M | Sell |
8,029,340
-6,195,708
| -44% | -$257M | 0.59% | 43 |
|
|
2018
Q3 | $595M | Buy |
14,225,048
+653,936
| +5% | +$25.2M | 0.88% | 21 |
|
|
2018
Q2 | $467M | Buy |
13,571,112
+446,218
| +3% | +$15.2M | 0.7% | 29 |
|
|
2018
Q1 | $442M | Sell |
13,124,894
-2,720,032
| -17% | -$93.5M | 1.21% | 13 |
|
|
2017
Q4 | $545M | Sell |
15,844,926
-522,828
| -3% | -$17.8M | 1.52% | 8 |
|
|
2017
Q3 | $554M | Buy |
16,367,754
+34,635
| +0.2% | +$1.11M | 1.59% | 9 |
|
|
2017
Q2 | $521M | Sell |
16,333,119
-3,884,135
| -19% | -$122M | 1.5% | 10 |
|
|
2017
Q1 | $656M | Buy |
20,217,254
+397,518
| +2% | +$12.5M | 1.85% | 4 |
|
|
2016
Q4 | $611M | Sell |
19,819,736
-1,115,177
| -5% | -$34M | 1.79% | 8 |
|
|
2016
Q3 | $673M | Buy |
20,934,913
+1,198,764
| +6% | +$40.1M | 2.01% | 4 |
|
|
2016
Q2 | $659M | Sell |
19,736,149
-3,565,183
| -15% | -$114M | 2.1% | 4 |
|
|
2016
Q1 | $655M | Buy |
23,301,332
+2,171,544
| +10% | +$62M | 2.03% | 4 |
|
|
2015
Q4 | $647M | Buy |
21,129,788
+645,067
| +3% | +$20.3M | 1.97% | 4 |
|
|
2015
Q3 | $610M | Buy |
20,484,721
+2,541,947
| +14% | +$81.5M | 2.12% | 2 |
|
|
2015
Q2 | $571M | Sell |
17,942,774
-666,389
| -4% | -$21.7M | 1.82% | 4 |
|
|
2015
Q1 | $614M | Buy |
18,609,163
+4,565,385
| +33% | +$145M | 1.98% | 4 |
|
|
2014
Q4 | $415M | Buy |
14,043,778
+12,255,143
| +685% | +$351M | 1.43% | 11 |
|
|
2014
Q3 | $50.2M | Buy |
1,788,635
+15,202
| +0.9% | +$427K | 0.19% | 129 |
|
|
2014
Q2 | $49.9M | Sell |
1,773,433
-1,952,899
| -52% | -$55.7M | 0.19% | 132 |
|
|
2014
Q1 | $114M | Buy |
3,726,332
+242,924
| +7% | +$7.24M | 0.41% | 66 |
|
|
2013
Q4 | $101M | Buy |
3,483,408
+1,133,539
| +48% | +$33M | 0.41% | 75 |
|
|
2013
Q3 | $64M | Sell |
2,349,869
-5,376,899
| -70% | -$146M | 0.31% | 92 |
|
|
2013
Q2 | $205M | Buy |
+7,726,768
| New | +$213M | 1.16% | 12 |
|
Other funds holding PFE
VCM
VPM
Fidelity International's PFE Position: Q1 2026 in Review
Fidelity International reduced its Pfizer (PFE) stake by 5.4% in Q1 2026, selling an estimated $13.3M and leaving 8,751,327 shares worth $246M. The position accounts for 0.19% of the portfolio, ranked #134.
Fidelity International first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $673M in Q3 2016. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Fidelity International held 8,751,327 shares of Pfizer worth $246M as of Q1 2026.
- Fidelity International sold 499,825 Pfizer shares in Q1 2026, an estimated $13.3M.
- Pfizer made up 0.19% of Fidelity International's portfolio in Q1 2026, its #134 holding.
- Fidelity International first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Fidelity International's Pfizer position peaked at $673M in Q3 2016.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.